High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome
Martine E.D. Chamuleau(Hovon), G.J. Ossenkoppele(Amsterdam UMC Location Vrije Universiteit Amsterdam), Jeroen J. W. M. Janssen(Radboud University Nijmegen), A. Zevenbergen(Amsterdam UMC Location VUmc), Bob Löwenberg(Unknown), Peter J.M. Valk(Erasmus MC Cancer Institute), Corine J. Hess(Amsterdam UMC Location VUmc), R Delwel(Erasmus University Rotterdam), Arjan A. van de Loosdrecht(Dutch Cancer Society)
Cited by 99
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k